Risk factors for congestive heart failure after aortic valve replacement with a Carpentier-Edwards pericardial

Wilhelm P Mistiaen1, Philip Van Cauwelaert, Philip Muylaert

  • 1University of Antwerp, Antwerp, Belgium. wihelm.mistiaen@ua.ac.be

Insights

Congestive heart failure (CHF) after aortic valve replacement (AVR) can be reduced by addressing preoperative conduction defects and atrial fibrillation (AF). Minimizing cross-clamp time and prompt surgery are also key to reducing CHF risk post-AVR.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Medical Research

Background:

  • Congestive heart failure (CHF) is a significant cause of morbidity following aortic valve replacement (AVR).
  • Identifying preoperative risk factors for CHF is crucial for improving patient outcomes after AVR.

Purpose of the Study:

  • To identify preoperative risk factors associated with the development of congestive heart failure (CHF) after aortic valve replacement (AVR).

Main Methods:

  • Retrospective analysis of 500 patients undergoing AVR with a Carpentier-Edwards pericardial valve.
  • Investigation of 15 potential risk factors using univariate and multivariate statistical analyses.
  • Assessment of CHF development during hospital stay and long-term follow-up.

Main Results:

  • During hospitalization, urgent operation, preoperative atrial fibrillation (AF), and NYHA functional class IV were significant risk factors for CHF.
  • Long-term follow-up revealed that smaller valve size (<19 mm), preoperative conduction defects, postoperative AF, longer cross-clamp time (>75 min), NYHA class IV, coronary artery disease (CAD), and additional coronary artery bypass grafting (CABG) were significant.
  • Multivariate analysis identified preoperative conduction defects, postoperative AF, and CAD as independent risk factors for long-term CHF.

Conclusions:

  • Morbidity from CHF after AVR can be minimized by effectively treating atrial fibrillation (AF) and conduction defects.
  • Preoperative factors like patient age, valve size, and cross-clamp time were not independent predictors of CHF.
  • Optimizing surgical timing, minimizing cross-clamp duration, and managing AF and conduction defects are recommended to reduce CHF post-AVR.
Abstract

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...